Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 4 November 2026.

Announcements

6,263

Total raised

£165B

disclosed amounts

This month

£177M

raised so far

Series A
£5.0M

Frog Capital led the investment round, which will support platform enhancements and international expansion.

"The world of intelligence and investigations is no longer constrained to policing, there is much wider application. Organisations are under growing scrutiny, finding themselves more susceptible to threats and with a much greater duty of care towards the vulnerable."
— Clare Elford, CEO
Series D+
£60.0M

The financing round was backed by Tencent, British Patient Capital, CMB International, Mayfair Equity Partners, and IP Group.

"The metaverse concept is not new to Ultraleap. It has always been our mission to remove boundaries between physical and digital worlds. The pandemic has accelerated the rise of the term as more people now understand the power of enhancing the physical world with digital elements."
— Tom Carter, CEO
Series A
£4.0M

The London-based adtech company has raised fresh capital from Mercia to scale its operations internationally.

"Mobile has become the primary means of consuming content, yet the majority of mobile advertising remains static. Adludio is redefining mobile advertising and is recognised as a leader in the field. We are delighted to be backing the company on the next stage of its journey. The combination of established international traction and scalable technology alongside this fresh capital leaves the business in great shape to grow rapidly in the coming years."
— Jason Warren, Investment Director
Seed
£1.9M

The seed round was co-led by Oxford Capital and YZR to fund expansion into international markets.

"Increasing access to the right diagnostic imaging and testing is vital to saving lives. It offers preventive healthcare that, if delayed, can cause significant problems to the patient and put even greater pressure on the healthcare system. In my role as an osteopath I've seen how the deterioration of patient wellbeing can be impacted by the cost and access of such tests. With this new investment we can continue to grow our network to get the tests that help to direct patients to the optimal therapy for the best outcome."
— Jasper Nissim, Co-Founder and UK Managing Director
Series A
$6.0M

Adelie Capital and Greenwood Way Capital backed the round, which will fund team expansion.

"This is a major achievement in the development of our company. Our Investors share our commitment to empower asset owners, managers, and advisors by delivering a more enriched experience for managing their investments and making decisions on one single version of the truth. This investment will support our aggressive growth plans to become the vendor of choice for investment reporting and analytics in our target markets."
— Benjamin Moute, CEO